CAB-AXL-ADC

· BioAtla, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CAB-AXL-ADC, covering 2025-09-23 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC [Phase 2]